 Lansing Taylor originally did research on the cellular and molecular mechanisms of Amoeboid movements at Harvard University as an assistant and associate professor.He moved to Carnegie Mellon University (CMU) as a professor to direct the Center for Fluorescence Research where he led the program to develop fluorescence-based biosensors of cellular physiology and light microscope imaging systems for various applications in basic biomedical research.During this time he co-founded Biological Detection Systems to commercialize fluorescence-based reagents and research imaging platforms, later purchased by Amersham, now GE Life Sciences.